Report me for selling fake medicine? Why are you crying when your illness relapses?

Since Anna said "originally", it proves that the 300 billion yuan offer is not the final decision, and there should be a latest plan.

And he was not wrong, Anna continued speaking.

"Then I discovered you weren't very interested in selling the new drug formula."

"In other words, even if we offer 300 billion, we still won't be able to impress you."

“So, I discussed it with other Novartis executives and eventually came up with a new plan.”

Anna paused here.

Obviously, she wanted to see Chen Xuan's reaction.

"Oh? Tell me about it." Chen Xuan became a little interested.

He was very curious about what option would be better than a 300 billion acquisition?

"I hope to achieve cooperation between the two sides through equity exchange."

"Novartis is exchanging 3% of its shares for 60% of Antai Pharmaceutical Group's shares."

Anna said directly, "I wonder if Mr. Chen is interested in this kind of cooperation plan? We can discuss the specific details slowly."

This plan was also something she suddenly thought of after coming to China.

It would probably be difficult to get Chen Xuan to agree to directly purchase the formula of the lung cancer drug, so this is the only roundabout solution he could think of.

If Novartis can control the shares of Antai Pharmaceutical Group, it will be equivalent to controlling the patent for the lung cancer drug.

In particular, the 60% stake makes Antai Pharmaceutical Group equivalent to a subsidiary of Novartis, which is no longer a difference.

Hearing this, Chen Xuan found it a bit interesting.

I have to say that this plan is very thoughtful and sincere.

After Novartis acquired the formula for a special liver cancer drug, its stock price has been rising steadily, and its market value has now exceeded US$200 billion.

In other words, 3% of Novartis' shares are worth more than 60 billion US dollars, which is almost 420 billion RMB!

At a price of 420 billion yuan, it only acquired 60% of the shares of Antai Pharmaceutical Group. Compared with Antai Group, its valuation has reached 700 billion yuan.

In contrast, Changfeng Group wants to use 120 billion to acquire 60% of the shares of Antai Pharmaceutical Group.

And AbbVie only offered 320 billion, but wanted the complete formula of lung cancer medicine and 60% of the shares.

Novartis directly offered shares worth 420 billion yuan, while only 60% of Antai Pharmaceutical Group's shares are required. There is a huge difference.

In comparison, Novartis' sincerity appears to be greater.

Of course, Anna only gave such a premium because of Chen Xuan's potential. If it weren't for him, Novartis would never have offered such a price for a formula.

There is such potential for a specific drug for lung cancer, but this potential is empty until it passes clinical trials.

If it can pass clinical trials and be approved for marketing, not to mention 500 billion, even 1000 billion is possible.

But before that, any valuation is a risky investment, and the high or low valuation affects the level of investment risk.

Therefore, Anna focused more on Chen Xuan's potential, betting that he could develop new special medicines in the future.

For this reason, after the equity exchange, the agreement must also contain provisions, such as stipulating that he must stay in Antai Pharmaceutical Group for a long time and continue to develop new drugs for the company in the future.

Provisions like this will definitely appear in the equity exchange agreement, and the bet is on his future new achievements, not just a drug.

Of course, if he can develop new drugs, Novartis will definitely provide new subsidies. It is impossible for him to work for the company in vain. This is another new agreement.

But it doesn't matter what.

Anna was able to come up with this kind of cooperation plan.

First, he is optimistic about the future rights of the special medicine for lung cancer, and second, he is very optimistic about the value of Chen Xuan as a person.

She wants both, so she can achieve this through equity exchange. This is the best and most sincere option.

……

……

As for Anna's proposal,

Chen Xuan could only say that the other party was very sincere, and at the same time he was also impressed by the other party's cleverness.